Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
3.970
+0.040 (1.01%)
Mar 31, 2025, 2:31 PM EDT - Market open
Genenta Science Employees
Genenta Science had 14 employees as of December 31, 2023.
Employees
14
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$659,081
Market Cap
72.61M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GNTA News
- 12 days ago - Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates - GlobeNewsWire
- 2 months ago - TOP ITALIAN AND U.S. LIFE SCIENCES EXECUTIVES AND ITALIAN GOVERNMENT LEADERS SHARED BUSINESS SUCCESS STORIES WITH INVESTORS AT "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE - PRNewsWire
- 2 months ago - Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing - GlobeNewsWire
- 2 months ago - ITALIAN TRADE AGENCY TO HOST "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE - PRNewsWire
- 5 months ago - Genenta's CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective” - GlobeNewsWire
- 6 months ago - Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer - GlobeNewsWire
- 11 months ago - Genenta Welcomes New Directors John L. Cantello, Lauren H. - GlobeNewsWire
- 1 year ago - Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors - GlobeNewsWire